NATURALLY SPLENDID ENTERPRISES LTD. (“Naturally Splendid” or “NSE”) (TSXV:NSP)(OTC:NSPDF)(FRANKFURT:50N) is pleased to announce that HempOmega(TM) client, Sipp Industries Inc. (“SIPP”), has signed a distribution agreement with Mahaska Bottling Company (“Mahaska”) to distribute Hemp infused IPA, Major Hemp HIPA, throughout the state of Iowa.

Sipp’s new Hemp infused IPA, and Major Hemp H-IPA, both utilize Naturally Splendid’s propriety microencapsulated hemp oil, HempOmega(TM), in the formula of these beers creating unique, competitive advantages. HempOmega(TM) fortified beer can now be purchased in over 7 states. Efforts continue to secure the necessary approvals for HempOmega(TM) infused beers in the states of Texas and California.

Sipp is currently in the process of fulfilling the initial order of Major Hemp HIPA, which will be distributed by Mahaska Bottling Company throughout Iowa’s largest cities including Des Moines, Cedar Rapids and Davenport, as well as popular college towns in Iowa City and Ames. Mahaska Bottling Company offers a full-array of services and distribution in Iowa, Kansas and Nebraska, along with parts of Illinois, Missouri and South Dakota. Mahaska also offers proprietary brands, products and services in California, Texas and New York.

Ted Jorgensen, President of wholly-owned subsidiary Major Hemp, commented, “We are very excited to enter the Iowa market which is a state with a true passion for craft beer. Mahaska is an excellent partner to distribute Major Hemp HIPA in Iowa and we expect to ship out their initial order this week.”
Naturally Splendid CEO Douglas Mason states,” We are very pleased with the continued success Sipp has had with HempOmega(TM) infused Major Hemp HIPA. The launch of their new Hemp infused IPA , which also contains our proprietary HempOmega(TM) is another positive step forward as our innovative technology continues to be validated with additional market applications. We would like to congratulate Sipp and look forward to supporting them in their continued efforts to penetrate the US craft been market.”

Sipp has also announced it has signed a contract with Craft Brand Ambassadors, LLC (“CBA”) to become an official brand ambassador of Major Hemp HIPA. CBA connects breweries, wineries and distilleries to distributors and covers midwestern states including Illinois, Iowa, Minnesota, Missouri and Michigan.

Dale Paulsen, Chief Executive Officer of CBA, stated, “We’re thrilled to be working with Sipp Industries on the distribution of Major Hemp HIPA. Initial sales have been strong and we continue to receive heavy interest from our partners.”

“A partnership with Dale and his team at CBA is already paying dividends with the vast distribution network they have in the Midwest. With the popularity and high ratings of Major Hemp HIPA, we expect to add more distributors and states over the coming weeks,” stated Syman Vong, Sipp Chief Executive Officer.

About Sipp Industries, Inc.

For more information, please visit www.

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp cannabinoid compounds in a broad spectrum of applications.

For more information e-mail or call Investor Relations at

On Behalf of the Board of Directors

Mr. Douglas Mason

CEO, Director

Contact Information

Naturally Splendid Enterprises Ltd.

(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)

#108-19100 Airport Way

Pitt Meadows, BC, V3Y 0E2

Office: (604) 465-0548

Fax: (604) 465-1128



Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications, including its application to obtain a Standard Processing License, may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.


Click here to connect with Naturally Splendid (TSXV:NSP) for an Investor Presentation.

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less